Studies of safety, infectivity and immunogenicity of a new temperature-sensitive (ts) 51-1 strain of Salmonella typhi as a new live oral typhoid fever vaccine candidate
Authors:
- J.A. BellantiJBJ.A. Bellanti
- B.J. ZeligsBZB.J. Zeligs
- S. VetroSVS. Vetro
- Y.-H. PungYPY.-H. Pung
- S. LuccioliSLS. Luccioli
- M.J. MalavasicMMM.J. Malavasic
- A.M. HookeAHA.M. Hooke
- T.R. UbertiniTUT.R. Ubertini
- R. VanniRVR. Vanni
- L. NencioniLNL. Nencioni
Open Access
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Lack of Immune Response to the Vi Component of a Vi-Positive Variant of the Salmonella typhi Live Oral Vaccine Strain Ty21a in Human StudiesThe Journal of Infectious Diseases, 1991
- Comparison of enteric-coated capsules and liquid formulation of Ty21a typhoid vaccine in randomised controlled field trialThe Lancet, 1990
- Progress in Vaccines Against Typhoid FeverClinical Infectious Diseases, 1989
- Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice.The Journal of Immunology, 1983
- A Controlled Field Trial of Live Salmonella typhi Strain Ty 21a Oral Vaccine Against Typhoid: Three-Year ResultsThe Journal of Infectious Diseases, 1982
- Evaluation of a UDP-Glucose-4-Epimeraseless Mutant of Salmonella typhi as a Live Oral VaccineThe Journal of Infectious Diseases, 1977
- Isolation and Characterization of Gal E Mutant Ty 21a of Salmonella typhi: A Candidate Strain for a Live, Oral Typhoid VaccineThe Journal of Infectious Diseases, 1975